welbournes

/welbournes

About welbournes

This author has not yet filled in any details.
So far welbournes has created 537 blog entries.

September 2022 Price Concessions 1st Update

The Department of Health and Social Care (DHSC) has today (20/09/2022) granted the following initial list of price concessions: Drug Pack size Price concession Alendronic acid 70mg tablets 4 £11.45 Amisulpride 100mg tablets 60 £13.94 Amisulpride 200mg tablets 60 £28.57 Amisulpride 50mg tablets 60 £9.20 Amorolfine 5% medicated nail lacquer 5 £7.34 Amoxicillin 250mg/5ml oral [...]

The post September 2022 Price Concessions 1st Update appeared first on PSNC Website.

By |September 20th, 2022|Lexpos News|Comments Off on September 2022 Price Concessions 1st Update

Medicine Supply Notification: Temazepam 10mg and 20mg tablets

Department of Health and Social Care (DHSC) has issued a medicine supply notification for Temazepam 10mg and 20mg tablets. MSN/2022/078 Tier 2 – medium impact Date of issue 15th September 2022 Temazepam 10mg and 20mg tablets are in limited supply until w/c 5th December 2022 Alternative benzodiazepines and non-benzodiazepine hypnotics remain available and will be [...]

The post Medicine Supply Notification: Temazepam 10mg and 20mg tablets appeared first on PSNC Website.

By |September 15th, 2022|Lexpos News|Comments Off on Medicine Supply Notification: Temazepam 10mg and 20mg tablets

MHRA Class 4 Medicines Defect Information: Atorvastatin 4mg/ml Oral Suspension & Sildenafil 10mg/ml Oral Suspension (Rosemont Pharmaceuticals Ltd)

Class 4 Medicines Defect Information: Atorvastatin 4mg/ml Oral Suspension & Sildenafil 10mg/ml Oral Suspension (Rosemont Pharmaceuticals Ltd) Drug alert number: EL (22)A/39 Date issued: 14 September 2022 The Medicines and Health products Regulatory Agency (MHRA) has issued a class 4 medicines defect information notice for: Atorvastatin 4mg/ml Oral Suspension PL 00427/0256 Batch Number Expiry Date [...]

The post MHRA Class 4 Medicines Defect Information: Atorvastatin 4mg/ml Oral Suspension & Sildenafil 10mg/ml Oral Suspension (Rosemont Pharmaceuticals Ltd) appeared first on PSNC Website.

By |September 14th, 2022|Lexpos News|Comments Off on MHRA Class 4 Medicines Defect Information: Atorvastatin 4mg/ml Oral Suspension & Sildenafil 10mg/ml Oral Suspension (Rosemont Pharmaceuticals Ltd)

Medicine Supply Notification: Estradiol (Estraderm MX® ) 25micrograms/24hours and 100micrograms/24hours transdermal patches

Department of Health and Social Care (DHSC) has issued a medicine supply notification for Estradiol (Estraderm MX®) 25micrograms/24hours and 100micrograms/24hours transdermal patches. MSN/2022/076 Tier 2 – medium impact Date of issue 8th September 2022 Estradiol (Estraderm MX®) 25micrograms/24hours transdermal patches are out of stock until w/c 12th September 2022. Intermittent supply issues are subsequently expected until [...]

The post Medicine Supply Notification: Estradiol (Estraderm MX® ) 25micrograms/24hours and 100micrograms/24hours transdermal patches appeared first on PSNC Website.

By |September 8th, 2022|Lexpos News|Comments Off on Medicine Supply Notification: Estradiol (Estraderm MX® ) 25micrograms/24hours and 100micrograms/24hours transdermal patches

Medicine Supply Notification: Medroxyprogesterone (Provera® ) 10mg tablets

Department of Health and Social Care (DHSC) has issued a medicine supply notification for Medroxyprogesterone (Provera®) 10mg tablets. MSN/2022/074 Tier 3 – high impact Date of issue 1st September 2022 Medroxyprogesterone (Provera®) 10mg tablets are in limited supply until mid-September 2022. Lower strength medroxyprogesterone tablets (2.5mg and 5mg) remain available but will not be able [...]

The post Medicine Supply Notification: Medroxyprogesterone (Provera® ) 10mg tablets appeared first on PSNC Website.

By |September 5th, 2022|Lexpos News|Comments Off on Medicine Supply Notification: Medroxyprogesterone (Provera® ) 10mg tablets